Labcorp Holdings (LH) Q2 Earnings and Revenues Top Estimates

Core Insights - Labcorp Holdings (LH) reported quarterly earnings of $4.35 per share, exceeding the Zacks Consensus Estimate of $4.14 per share, and up from $3.94 per share a year ago, representing an earnings surprise of +5.07% [1] - The company achieved revenues of $3.53 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 1.14%, and an increase from $3.22 billion year-over-year [2] - Labcorp has consistently outperformed consensus EPS estimates over the last four quarters, achieving this four times [2] Earnings Outlook - The future performance of Labcorp's stock will largely depend on management's commentary during the earnings call and the sustainability of the stock's immediate price movement based on the recently released numbers [3][4] - The current consensus EPS estimate for the upcoming quarter is $4.07 on revenues of $3.53 billion, while for the current fiscal year, the estimate is $16.05 on revenues of $13.91 billion [7] Industry Context - The Medical Services industry, to which Labcorp belongs, is currently ranked in the top 39% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8] - Another company in the same industry, IceCure Medical Ltd. (ICCM), is expected to report a quarterly loss of $0.06 per share, with revenues projected to decline by 20.8% year-over-year [9]